TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released June 5, 1987